Surgical Outcomes, Complications, and Mortality of Patients With Resectable NSCLC Treated With Neoadjuvant Chemoimmunotherapy Compared to Neoadjuvant Chemotherapy Alone in a Real-World Population

T. Ermer¹, E. Zolfaghari¹, J. Bader¹, M. Zaky¹, A. Shabazian², J. Blasberg³, D. Boffa⁴, S. Dacic¹, A. Dhanasopon⁵, G. A.. Woodard^6
1Yale New Haven Hospital, New Haven, Connecticut ²Yale New Haven Hospital, middletown, Connecticut ³Yale University School of Medicine, Westport, Connecticut ⁴Yale University School of Medicine, New Haven, Connecticut ⁵Yale University School of Medicine, Dept of Surgery, Section of Thora, New Haven, Connecticut ⁶Yale School of Medicine, New Haven, Connecticut